These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 37384372)

  • 21. Benefits and Concerns regarding Use of Cannabis for Therapeutic Purposes Among People Living with Chronic Pain: A Qualitative Research Study.
    AminiLari M; Kithulegoda N; Strachan P; MacKillop J; Wang L; Pallapothu S; Neumark S; Sharma S; Sethi J; Zacharias R; Blain A; Patterson L; Busse JW
    Pain Med; 2022 Oct; 23(11):1828-1836. PubMed ID: 35652734
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cohort study of medical cannabis authorisation and healthcare utilisation in 2014-2017 in Ontario, Canada.
    Eurich D; Lee C; Zongo A; Minhas-Sandhu JK; Hanlon JG; Hyshka E; Dyck J
    J Epidemiol Community Health; 2020 Mar; 74(3):299-304. PubMed ID: 31831619
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gaps in evidence for the use of medically authorized cannabis: Ontario and Alberta, Canada.
    Lee C; Round JM; Klarenbach S; Hanlon JG; Hyshka E; Dyck JRB; Eurich DT
    Harm Reduct J; 2021 Jun; 18(1):61. PubMed ID: 34103058
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cannabis companies and the sponsorship of scientific research: A cross-sectional Canadian case study.
    Grundy Q; Imahori D; Mahajan S; Garner G; Timothy R; Sud A; Soklaridis S; Buchman DZ
    PLoS One; 2023; 18(1):e0280110. PubMed ID: 36626363
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluating the Quality of Website Information of Private-Practice Clinics Offering Cell Therapies in Japan.
    Kashihara H; Nakayama T; Hatta T; Takahashi N; Fujita M
    Interact J Med Res; 2016 May; 5(2):e15. PubMed ID: 27222494
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Medical cannabis and cannabis-based medicine show both potential efficacy and potential harms: Cross-sectional comparison with controls on self-rated and interviewer-rated outcomes within the Danish pilot program on medical cannabis.
    Kudahl B; Berg ME; Posselt CM; Nordentoft M; Hjorthøj C
    Complement Ther Clin Pract; 2021 Nov; 45():101476. PubMed ID: 34425501
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Medical cannabis patterns of use and substitution for opioids & other pharmaceutical drugs, alcohol, tobacco, and illicit substances; results from a cross-sectional survey of authorized patients.
    Lucas P; Baron EP; Jikomes N
    Harm Reduct J; 2019 Jan; 16(1):9. PubMed ID: 30691503
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Medical Cannabis in Canadian Schools: A Scoping Review of Existing Policies.
    Awal M; Kelly LE; Anderson J; Brace T; Brown C; Buettner T; King PM; Klemmer J; Lougheed T; O'Shea K; Mansell H
    Cannabis Cannabinoid Res; 2022 Dec; 7(6):758-768. PubMed ID: 36251467
    [No Abstract]   [Full Text] [Related]  

  • 29. Effects of medical and non-medical cannabis use in older adults: protocol for a scoping review.
    Wolfe D; Corace K; Rice D; Smith A; Kanji S; Conn D; Willows M; Garber GE; Puxty J; Moghadam E; Skidmore B; Garritty C; Thavorn K; Moher D; Hutton B
    BMJ Open; 2020 Feb; 10(2):e034301. PubMed ID: 32114474
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Medical cannabis use in the Australian community following introduction of legal access: the 2018-2019 Online Cross-Sectional Cannabis as Medicine Survey (CAMS-18).
    Lintzeris N; Mills L; Suraev A; Bravo M; Arkell T; Arnold JC; Benson MJ; McGregor IS
    Harm Reduct J; 2020 Jun; 17(1):37. PubMed ID: 32513180
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The impact of legalization of access to recreational Cannabis on Canadian medical users with Cancer.
    Hawley P; Gobbo M; Afghari N
    BMC Health Serv Res; 2020 Oct; 20(1):977. PubMed ID: 33109169
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Attitudes Toward Medical Cannabis Legalization Among Serbian Medical Students.
    Vujcic I; Pavlovic A; Dubljanin E; Maksimovic J; Nikolic A; Sipetic-Grujicic S
    Subst Use Misuse; 2017 Jul; 52(9):1225-1231. PubMed ID: 28605305
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Use of Academic Research in Medical Cannabis Marketing: A Qualitative and Quantitative Review of Company Websites.
    Caputi TL
    J Stud Alcohol Drugs; 2022 Jan; 83(1):5-17. PubMed ID: 35040755
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cannabis for the treatment of Crohn's disease.
    Kafil TS; Nguyen TM; MacDonald JK; Chande N
    Cochrane Database Syst Rev; 2018 Nov; 11(11):CD012853. PubMed ID: 30407616
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A cross-sectional study of website claims related to diagnoses and treatment of non-musculoskeletal conditions.
    Jensen RK; Agersted MEI; Nielsen HA; O'Neill S
    Chiropr Man Therap; 2020 Mar; 28(1):16. PubMed ID: 32228649
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cannabis for medical purposes: A cross-sectional analysis of health care professionals' knowledge.
    Rice J; Hildebrand A; Waslo CS; Cameron MH; Jones KD
    J Am Assoc Nurse Pract; 2021 Mar; 34(1):100-106. PubMed ID: 33767121
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Attitudes and Beliefs Toward Cannabis Before Recreational Legalization: A Cross-Sectional Study of Community Adults in Ontario.
    Turna J; Balodis I; Van Ameringen M; Busse JW; MacKillop J
    Cannabis Cannabinoid Res; 2022 Aug; 7(4):526-536. PubMed ID: 33998851
    [No Abstract]   [Full Text] [Related]  

  • 38. Family attitudes about and experiences with medical cannabis in children with cancer or epilepsy: an exploratory qualitative study.
    Gibbard M; Mount D; Rassekh SR; Siden HH
    CMAJ Open; 2021; 9(2):E563-E569. PubMed ID: 34021014
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.